Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Gross Margin (2022 - 2025)

Envoy Medical's Gross Margin history spans 4 years, with the latest figure at 864.29% for Q3 2025.

  • For Q3 2025, Gross Margin fell 63036.0% year-over-year to 864.29%; the TTM value through Sep 2025 reached 462.5%, up 4757.0%, while the annual FY2023 figure was 427.22%, 31709.0% down from the prior year.
  • Gross Margin for Q3 2025 was 864.29% at Envoy Medical, down from 200.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 153.97% in Q2 2023 and bottomed at 1069.47% in Q4 2023.
  • The 4-year median for Gross Margin is 247.11% (2024), against an average of 380.37%.
  • The largest annual shift saw Gross Margin surged 21632bps in 2024 before it plummeted -63036bps in 2025.
  • A 4-year view of Gross Margin shows it stood at 655.0% in 2022, then tumbled by -63bps to 1069.47% in 2023, then surged by 78bps to 233.93% in 2024, then crashed by -269bps to 864.29% in 2025.
  • Per Business Quant, the three most recent readings for COCH's Gross Margin are 864.29% (Q3 2025), 200.0% (Q2 2025), and 678.26% (Q1 2025).